The Application Notebook
Bruker Daltonics
James Hillis, Petra Decker, Ian Sanders and Carsten Baessmann, Bruker Daltonics
The update to the SANCO guidelines in 2009 recognized the power and potential of time-of-flight (TOF) mass spectrometry for pesticide screening applications. When compared with historical screening tools (such as the use of triple-quad mass spectrometry), high performance accurate mass TOF systems offer several advantages for screening applications. These advantages include better resolution, unlimited multiple target capabilities and the possibility to perform comprehensive and/or retrospective analysis on samples in silico at will.
The maXis impact™ continues the evolution of Bruker's unique TOF accurate mass instruments. The performance of ≥40k resolution, ≤1ppm mass accuracy and high isotopic fidelity is maintained without sensitivity compromise. While acquisition at up to 50 Hz enables maXis impact to handle the fastest of ultra high performance liquid chromatography (UHPLC) separations with ease. Additionally, to aid in quantitative applications, the maXis impact delivers an increase in sensitivity of up to 50-fold over previous generation instruments, especially at the low m/z tandem mass spectrometry (MS–MS) signals important for analyte confirmation.
The dramatic increase in sensitivity changes the game for pesticide screening applications. With limits of detection (LODs) typically in the sub ng/mL levels, achieving excellent maximum residue levels (MRLs) becomes very easy. The maXis impact enables analysts to obtain both qualitative and quantitative results in a single analysis. Identification data including accurate mass MS and MS–MS, isotopic pattern fitting and Rt fitting can be readily collected and correlated in dedicated software. In the same run, sub ng/mL limits of quantification (LOQs) with dynamic ranges over four orders of magnitude can also be obtained (Figure 1).
Figure 1: Fluoxastrobin at 50 fg to 1 ng on column.
Taken together, the key qualitative and quantitative performance attributes of the maXis impact make it an excellent choice for routine pesticide screening applications with confirmation and quantitation in a single run. The maXis impact can provide comprehensive data quality that is unmatched by any other technology currently available.
A mixture of 200 pesticides was run on the PesticideScreener™ application. This mixture has previously been well characterized and publicized. This same mixture was used to assess the performance of the maXis impact and specifically to assess the increase in sensitivity observed.
The maXis impact changes the game in small molecule pesticide screening. Sensitivity increases of 20- to 50-fold versus previous systems are routine. This enhanced sensitivity, coupled with the additional capabilities of the maXis impact, allows both high quality qualitative and quantitative data to be acquired in a single run (Figure 1). The capabilities of the maXis impact are ideally suited to pesticide screening and quantification, and provides an unrivalled level of confidence at sub ppb levels.
To further optimize the use of the maXis impact for pesticide screening, the PesticideScreener application platform is a fully developed protocol, allowing the use of accurate mass and isotopic pattern fitting and retention time fitting, for straight-out-of-the-box implementation of this outstanding analytical system (Figure 2).
Figure 2: Overlapped hrEIC traces showing the evolution of TOF sensitivity.
The maXis impact sets the new gold standard for pesticide screening through full utilization of the capabilities of ultrahigh-sensitivity TOF accurate mass spectrometry.
Bruker Daltonics Inc.
40 Manning Road, Billerica, Massachusetts, USA
tel. (978) 663-3660, fax (978) 667-5993
Website: www.bruker.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.